Breast Lesion Localization Methods Market Projected to Surpass USD 1.58 Billion by 2025

The global breast lesion localization methods market size is expected to reach USD 1.58 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to witness a CAGR of 13.3% during the forecast period. Growing number of government and non-government reimbursement policies for the breast cancer diagnostics, biopsy, examination, and other medical procedures are estimated to increase the adoption of breast lesion localization methods. Moreover, high demand for better healthcare infrastructure and facilities due to rising prevalence of the target disease among women is expected to fuel the market growth.

It is more prevalent in women above the age of 50 years. Although it is majorly occurring in women, the male population has one in eight chances of being diagnosed with the target cancer. According to the WHO, almost 6.5% of all cancer-related deaths worldwide are caused by breast cancer. Increasing awareness level about breast cancer screening is expected to further enhance the market growth. For instance, in U.S., the Centre of Disease Control and Prevention’s National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides free access to timely breast and cervical diagnostic and screening services to the needy patients.

These screening programs include high-quality mammogram diagnosis, which involves breast X-rays, biopsies (if required), and an analytical judgment. Key companies, such as C.R. Bard, Inc.; Cianna Medical, Inc.; and Cook Medical, Inc. focus on business expansion in developing regions in an attempt to increase their market share. They are also adopting several other strategies, such as M&A and product launch. For instance, in October 2018, Cianna Medical, Inc. signed a merger agreement with Merit Medical Systems, Inc., in which the latter will provide clinical support for R&D to Cianna Medical, Inc. for commercializing new technologies in the market.

U.S. breast lesion localization methods market

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/breast-lesion-localization-methods-market

Further key findings from the study suggest:

  • The global breast lesion localization methods market was valued at USD 580.7 million in 2017 and is expected to grow lucratively over the forecast period
  • Wire-guided localization segment held the largest market share of 35.9% in 2017 owing to the presence of wide range of products and high adoption of this technique among end-users
  • Radioisotope localization is expected to witness significant growth over the forecast period as it is an effective, safe, and widely used procedure for preoperative localization of non-palpable, suspicious breast lesions
  • North America led the market with revenue of USD 209.96 million in 2017. The presence of key manufacturers in U.S., established healthcare infrastructure, and high adoption of localization devices are the factors responsible for its largest share
  • Asia Pacific is expected to witness the fastest CAGR of 15.3% during the forecast period due to increasing demand for breast conserving surgery.

Grand View Research has segmented the global breast lesion localization methods market on the basis of type and region:

Breast Lesion Localization Methods Type Outlook (Revenue, USD Million, 2014 – 2025)

  • Wire Guided
  • Radioisotope
    • Radio Guided Occult-Lesion Localization (ROLL)
    • Radioactive-Seed Localization (RSL)
    • Others
  • Magnetic Tracer
  • Others

Breast Lesion Localization Methods Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Boosting Demand Of Breast Lesion Localization Methods Market Due To Rising Prevalence Of Breast Cancer Among Women Till 2025

 

The global breast lesion localization methods market is expected to reach USD 1.57 billion by 2025, according to a new report by Grand View Research, Inc. The increasing government and non-government reimbursement policies for mammary gland cancer diagnosis, biopsy, pre-surgical examinations, and other treatment options is estimated to increase the adoption of breast lesion localization procedures. For instance, the Alabama Breast and Cervical Cancer Early Detection Program aims to provide breast and cervical oncology diagnostic and screening services to women who meet certain income, age, and insurance coverage eligibility guidelines.

us-breast-lesion-localization-methods-market.png
U.S. breast lesion localization methods, by type, 2014 – 2025 (USD Billion)

Furthermore, rising prevalence of breast cancer is anticipated to propel the market growth. The disease is highly prevalent amongst women belonging to the age group of 65 years or above. The maximum risk of mammary gland cancer is between the age of 70 and 79. On the other hand, men are also at a risk of breast cancer. In the U.S., median age of men at diagnosis is approximately 68 years.

Browse full research report on Breast Lesion Localization Methods Market: www.grandviewresearch.com/industry-analysis/breast-lesion-localization-methods-market                                                                                                                              

Further key findings from the report suggest:

  • Wire localization biopsy dominated the market in 2016 owing to its higher usage by healthcare practitioners, easy availability, and presence of a wide product range
  • Magnetic tracer is expected to grow at lucrative CAGR of 14.0% over the forecast period as a result of increasing adoption of MagSNOLL technology over conventional wire localization.
  • Radioisotope seed localization is considered the most preferred method amongst all radioisotope localization methods due to its benefits such as ease of localization few weeks before the excision surgery and lesser need for reoperation.
  • North America is estimated to be the largest regional market. It dominated the market in terms of revenue with USD 185.04 million in 2016 owing to the presence of well-established healthcare services and increasing number of oncology surgeries being performed.
  • In addition, early adoption of devices and shift from traditional to technologically advanced products by healthcare providers are some of the factors anticipated to increase the demand for localization devices in this region
  • Asia Pacific is expected to be the fastest growing region over the next decade with lucrative CAGR from 2017 to 2025 due to growing awareness about breast screening among the people. Furthermore, presence of a large target population and rising disposable income are some of the factors expected to propel the growth of this region.
  • Key players in this industry are Cianna Medical, Inc.; Cook Medical; STERYLAB; CP Medical; SOMATEX Medical Technologies; Argon Medical Devices, Inc.; and C.R BARD, Inc.
  • Most of the key players are focusing on strategies such as expansion of their product portfolios and collaborations, mergers, & acquisitions. In November 2015, C.R. BARD, Inc. announced the acquisition of Liberator Medical Holdings, Inc., a direct-to-customer distributor of medical products.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/healthcare                                           

Grand View Research has segmented the global breast lesion localization methods market on the basis of type and region:

Breast Lesion Localization Methods Type Outlook (Revenue, USD Million, 2014 – 2025)

  • Wire Localization biopsy
  • Radioisotope localization
    • Radio-guided occult lesion localization
    • Radioactive seed localization
    • Others
  • Magnetic tracer
  • Others

Breast Lesion Localization Methods Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-breast-lesion-localization-methods-market                              

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Breast Lesion Localization Methods Market Will Be Worth $1.57 Billion By 2025: Grand View Research, Inc.

The global breast lesion localization methods market is expected to reach USD 1.57 billion by 2025, according to a new report by Grand View Research, Inc. The increasing government and non-government reimbursement policies for mammary gland cancer diagnosis, biopsy, pre-surgical examinations, and other treatment options is estimated to increase the adoption of breast lesion localization procedures. For instance, the Alabama Breast and Cervical Cancer Early Detection Program aims to provide breast and cervical oncology diagnostic and screening services to women who meet certain income, age, and insurance coverage eligibility guidelines.

Furthermore, rising prevalence of breast cancer is anticipated to propel the market growth. The disease is highly prevalent amongst women belonging to the age group of 65 years or above. The maximum risk of mammary gland cancer is between the age of 70 and 79. On the other hand, men are also at a risk of breast cancer. In the U.S., median age of men at diagnosis is approximately 68 years.

U.S. breast lesion localization methods, by type, 2014 – 2025 (USD Billion)

 

us-breast-lesion-localization-methods-market.png

Browse full research report on Breast Lesion Localization Methods Market

Further key findings from the report suggest:

  • Wire localization biopsy dominated the market in 2016 owing to its higher usage by healthcare practitioners, easy availability, and presence of a wide product range
  • Magnetic tracer is expected to grow at lucrative CAGR of 14.0% over the forecast period as a result of increasing adoption of MagSNOLL technology over conventional wire localization.
  • Radioisotope seed localization is considered the most preferred method amongst all radioisotope localization methods due to its benefits such as ease of localization few weeks before the excision surgery and lesser need for reoperation.
  • North America is estimated to be the largest regional market. It dominated the market in terms of revenue with USD 185.04 million in 2016 owing to the presence of well-established healthcare services and increasing number of oncology surgeries being performed.
  • In addition, early adoption of devices and shift from traditional to technologically advanced products by healthcare providers are some of the factors anticipated to increase the demand for localization devices in this region
  • Asia Pacific is expected to be the fastest growing region over the next decade with lucrative CAGR from 2017 to 2025 due to growing awareness about breast screening among the people. Furthermore, presence of a large target population and rising disposable income are some of the factors expected to propel the growth of this region.
  • Key players in this industry are Cianna Medical, Inc.; Cook Medical; STERYLAB; CP Medical; SOMATEX Medical Technologies; Argon Medical Devices, Inc.; and C.R BARD, Inc.
  • Most of the key players are focusing on strategies such as expansion of their product portfolios and collaborations, mergers, & acquisitions. In November 2015, C.R. BARD, Inc. announced the acquisition of Liberator Medical Holdings, Inc., a direct-to-customer distributor of medical products

 

For more information: http://www.grandviewresearch.com